Replies to post #148078 on Biotech Values

[jq1234]

I don't know where 2019 date comes from. I have read Zytiga generic in 2015/2016 time frame for quite some time from other sources, which is consistent with Orangebook. This was the speculated reason why JNJ unblinded Zytiga prechemo ph3, prematurely as some argued.